An Alternative Splicing Isoform of MITA Antagonizes MITA-Mediated Induction of Type I IFNs

An Alternative Splicing Isoform of MITA Antagonizes MITA-Mediated Induction of Type I IFNs
复制标题

DOI:
10.4049/jimmunol.1300798
复制
发表时间:
2014-02-01
影响因子:
4.4
通讯作者:
Chen, Xinwen
Chen, Xinwen
中科院分区:
医学2区
文献类型:
--
作者:
Chen, Honghe;Pei, Rongjuan;Chen, Xinwen

文献摘要

被引文献

相似文献

干扰素调节转录因子3激活介体(Mediator of IFN Regulatory Transcription Factor 3 Activation,MITA)是介导I型干扰素诱导的重要衔接蛋白。在这项研究中,我们确定了一个选择性剪接异构体的MITA缺乏外显子7,称为MITA相关蛋白(MRP)。MRP与MITA共有N端氨基酸1-253,但在羧基端具有独特的30个氨基酸序列,因此缺乏保守的结构域,包括TANK结合激酶1(TBK 1)和环二鸟苷酸结合结构域。MRP在多种组织和不同的细胞系中表达。MRP的过表达抑制了仙台病毒感染和环二鸟苷酸处理引起的MITA介导的IFN-β启动子的激活,但增强了HSV-1感染引起的激活。有趣的是,MRP表达在仙台病毒感染后降低,但在HSV-1感染后上调。MRP的过表达通过破坏MITA-TBK 1相互作用来抑制MITA介导的经由TBK 1-IFN调节转录因子3的IFN-β诱导。然而,NF-κ B通路仍然被MRP激活,因为MRP保留了与NF-κ B(i kappa B)激酶的可诱导抑制剂相互作用的能力。因此,MRP作为MITA介导的IFN产生诱导的显性负调节因子。
Mediator of IFN regulatory transcription factor 3 activation (MITA) is an important adaptor protein to mediate the induction of type I IFNs. In this study, we identified an alternatively spliced isoform of MITA lacking exon 7, termed MITA-related protein (MRP). MRP shares the N-terminal portion aa 1-253 with MITA but possesses a unique 30-aa sequence at the carboxyl terminal part, therefore lacking the conserved domains including TANK-binding kinase 1 (TBK1) and cyclic diguanylate binding domain. MRP is expressed in multiple tissues and distinct cell lines. Overexpression of MRP inhibited MITA-mediated activation of IFN-beta promoter by sendai virus infection and cyclic diguanylate treatment but enhanced that in HSV-1 infection. Interestingly, MRP expression was reduced after Sendai virus infection but was upregulated after HSV-1 infection. Overexpression of MRP inhibited MITA-mediated induction of IFN-beta via TBK1-IFN regulatory transcription factor 3 by disrupting the MITA-TBK1 interaction. However, NF-kappa B pathway was still activated by MRP, as MRP retained the ability to interact with inducible inhibitor of NF-kappa B (i kappa B) kinase. Thus, MRP acts as a dominant negative regulator of MITA-mediated induction of IFN production.